Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

A double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders  

The project is a controlled study of oral, liquid L-carnitine administered to 20 children with autism spectrum disorder (ASD) and 10 typical controls. It is hypothesized that blood carnitine levels in children with ASD have a significant impact on behavior, cognition, and socialization. Outcome will be judged by behavior and cognition metrics, muscle strength testing, and lab tests. Project Status
NEW

2009

Funder Autism Research Institute
Fiscal Year Funding $11,882.00
Project Number 2009-11
Principal Investigator Geier, Mark
Received ARRA Funding? No
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Interventions)
Strategic Plan Objective Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4SC. Test safety and efficacy of at least five widely used interventions (e.g., nutrition, medications, assisted technologies, sensory integration, medical procedures) that have not been rigorously studied for use in ASD by 2012. IACC Recommended Budget: $27,800,000 over 5 years.
Federal or Private? Private
Institution Institute of Chronic Illnesses, Inc.
State/Country Maryland
Web Link 1 A double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders (External web link)
Web Link 2 No URL available.
Web Link 3 No URL available.
New! History/Related Projects Not available at this time. This functionality is experimental.